We have pursued a gene-based approach to generate this protective immunity, building on the evidence that heterologous prime-boost immunization induces CD8+ T cells and protection against malaria in mice [10], [11], non-human primates [12] and humans [13]–[20]. The gene discussed is CD8A; the disease is malaria.